82
Participants
Start Date
February 3, 2021
Primary Completion Date
May 5, 2023
Study Completion Date
May 5, 2023
Dialyser
Three consecutive treatment periods of four weeks, one last study week where the patient is re-assigned to the same type of dialyzer used before beginning the study and one follow-up week per patient. Each treatment period includes 12 hemodiafiltration HDF sessions and is assigned to one type of dialyzer: FX CorAL 600 Fresenius Medical Care, comparator FX CorDiax 600 Fresenius Medical Care and comparator xevonta Hi 15 (B. Braun).
Péterfy II. Dialízis Központ, Budapest
Váci Dialízis Központ, Vác
PHV Dialysezentrum Kiel, Kiel
Diakonissenkrankenhaus Flensburg, Flensburg
Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen, Hanover
PHV-Dialysezentrum Goslar, Goslar
Fresenius Nephrocare Nymburk, Nymburk
Fresenius Nephrocare Praha 9 - Vysocany, Prague
Institut Dr. Schauerte GmbH (IDS)
UNKNOWN
Fresenius Medical Care Deutschland GmbH
INDUSTRY